ID: MRFR/HC/8664-HCR | February 2021 | Region: Global | 108 pages
Global Protein Therapeutics Market is expected to cross USD 290,691.88 Million by 2027 at a CAGR of 6.86%.
Therapeutic protein drugs is one of the important class of medicines. These drugs are used in the treatment and management of different diseases, such as cancer and infectious diseases. Protein therapeutic drugs have significant potential to improve human health, and hence in the future, the demand for these drugs is likely to increase significantly.
The rising prevalence of chronic disorders such as diabetes is expected to influence the market growth during the forecast period. According to the report published by The International Diabetes Federation (IDF), in 2019, around 463 million adults (20-79 years) had diabetes, and by the end of 2045, this number is expected to reach 700 million. Similarly, other chronic disorders are growing at a high rate, which is likely to influence the demand for protein therapeutics around the world in the coming years.
By Protein Function
|Market Size||2027: USD 290,691.88 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Type, Application, Protein Function, End User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Abbott Laboratories (US), Amgen Inc. (US), Baxter International Inc. (US), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd. (Switzerland), Johnson & Johnson (US), Merck & Co., Inc. (US), Novo Nordisk A/S (Denmark), CSL Behring (US), Bristol Myers Squibb Co. (US), Pfizer Inc. (US), Sanofi (France), and Biogen, Inc. (US).|
|Key Market Opportunities||
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
Global Protein Therapeutics Market is anticipated to hold a value of USD 290,691.88 million by 2027.
Global Protein Therapeutics Market is anticipated to thrive at a CAGR of 6.86% by 2027.
The swift technological development in the field of protein therapeutics is anticipated to be one of the most important factors driving the Global Protein Therapeutics Market.
Global Protein Therapeutics Market can be segmented on the basis of type, application, end-user, protein function, and region.
Abbott Laboratories, Biogen, Inc., Amgen Inc., Baxter International Inc., Johnson & Johnson, Eli Lilly and Company, Hoffmann-La Roche Ltd, Merck & Co., Inc., Bristol Myers Squibb Co., Novo Nordisk A/S, CSL Behring, Pfizer Inc., and others are some of the eminent players of the Global Protein Therapeutics Market.
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.